Pulmonary Complications in Patient with Ulcerative Colitis,  Treated with 5-Aminosalicylic Preparations

Piotr Radwan; Tomasz Łupina; Karolina Radwan-Kwiatek; Janusz Milanowski

doi:10.5603/ARM.28056

You are currently viewing a new version of our website. To view the old version click .

Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.

Case Report

10 June 2006

Pulmonary Complications in Patient with Ulcerative Colitis, Treated with 5-Aminosalicylic Preparations

and

Katedra i Klinika Gastroenterologii AM, ul. Jaczewskiego 8, 20-950 Lublin, Poland

Katedra i Klinika Pneumonologii, Onkologii i Alergologii AM, ul. Jaczewskiego 8, 20-950 Lublin, Poland

Author to whom correspondence should be addressed.

Adv. Respir. Med.2006, 74(2), 224-226;https://doi.org/10.5603/ARM.28056

Version Notes

Order Reprints

Abstract

Pulmonary complications in patients with ulcerative colitis treated with 5-aminosalicylic acid are infrequent adverse events. The authors present a 35-year-old man, talcing sulfasalazine and mesalazine in whom pulmonary abnormalities resembling tuberculosis were observed during several months of therapy. Withdrawal of mesalazine resulted in complete resolution of lung injury. Patient is doing well on maintenance treatment with immunosuppressants.

Keywords:

ulcerative colitis; pulmonary complications; 5-aminosalicylic acid

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Latent Tetany Masked by Syndroms of Bronchial Asthma and Depressive Syndrome. Case Raport

Bacteria of the Genus Acinetobacter: Clinical Significance And Therapy of Infections